This study: 1) proposes the existence of metabolic heterogeneity in LSC; 2) finds a role of CD36+ LSC in tumor progression; and 3) suggests that FA metabolism modulation may contribute to eradicating LCS. The gene discussed is CD36; the disease is neoplasm.